The independent source for health policy research, polling, and news.
1,561 - 1,580 of 112,850 Results
The measure renews a public health program brought in during the first Trump administration. It includes services to help with drug addiction and mental health. Also in the news: A well-known vaccine critic is the new chief science officer at HHS.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health issues.
One proposed change to the star rating system is bringing back the “reward factor.” This provision, previously used until 2023, would increase payments to insurers that perform well. As a result, Medicare is scrapping the “health equity index” that was set to go into effect in 2027.
The study, published Monday, found that the younger kids were when they got their first smartphones, the greater their risk of obesity, depression, and poor sleep. Also: Some mental health apps are looking to integrate generative AI chatbots.
Mixed signals from the president are muddying the path forward on health care as Congress returns to session today. Also: Charities that help those with outstanding medical bills report seeing a troubling increase in requests for help, and they warn it could get worse as Medicaid cuts take effect.
The FDA said it will submit a new proposal to regulate an even broader range of talc-containing products in an effort to reduce exposure to the carcinogen. Other news is on "less lethal" crowd-control tactics, heating assistance, and more.
Dozens of boxes of records undisclosed until now have allegedly shown that New York City officials "had real testing done. And when that testing was done, it was suppressed. And everyone was told the air was safe; people would have made different choices," a union official said. Also: An FDNY deputy chief whose firefighter son died on 9/11 has also now died of World Trade Center-related illnesses.
Vaccine regulator Vinay Prasad, whose memo calls for stricter vaccine regulation, needs to make public the evidence that directly ties the shots to fatal outcomes, scientists say. In other vaccine news, scientists are studying more modern techniques for making shots.
Today's early morning highlights from the major news organizations.
The bill from Rep. Robin Kelly, a Democrat from Illinois, would require clinical justification for discharging patients presenting with signs or symptoms of labor, an assessment of travel distance, a confirmed back-up hospital or birthing facility, verification that patients have reliable transportation, and documentation of patient understanding, Becker's Hospital Review reported.
CMS may nix a dozen Medicare Advantage and Part D measures that focus on operational performance or completion of administrative processes. Other health industry news is on Humana's plan to appeal a court loss over the Medicare Advantage star ratings, Asheville's Mission Hospital is removed from immediate jeopardy by CMS, and more.
Of the three infant fatalities, none of the babies or their mothers had been vaccinated against the highly contagious whooping cough. Kentucky has reported 566 confirmed cases of pertussis this year, which is the largest outbreak since 2012. Also: norovirus, measles, RSV, flu, and covid.
“Some kind of an extension may be necessary to get something else done," President Donald Trump said Tuesday. But he added: “Somebody said I wanna extend them for two years. I don’t want to extend them for two years. I’d rather not extend them at all."
Editorial writers examine these public health topics.
The Centers for Disease Control and Prevention's internal database lists Dr. Ralph Abraham, 71, as its principal deputy director, with a start date of Nov. 23, The New York Times reported. Abraham is also the former surgeon general of Louisiana and halted the state health department’s mass vaccination campaigns.
Some prescription cancer drugs are also included in the negotiations. The announcement followed the second round of talks with pharmaceutical manufacturers under a new system implemented by the Biden administration as part of the 2022 Inflation Reduction Act, The Washington Post reported.
Today's early morning highlights from the major news organizations. Note to readers: The First Edition will not be published Thursday or Friday. Look for it again in your inbox on Monday, Dec. 1. Wishing you all a happy Thanksgiving!
Opinion writers tackle these public health topics.
Separately, Novo Nordisk's semaglutide did not slow the progression of Alzheimer's disease more than a placebo, even though some disease-related biomarkers did show some improvement. Also: GLP-1s are being marketed to the non-obese; pregnancy risks from GLP-1s; and more.
© 2026 KFF